- Home
- BHVN vs SCZM Comparison
BHVN vs SCZM Comparison
Compare BHVN & SCZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHVN | SCZM |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.2B |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | BHVN | SCZM |
|---|---|---|
| Price | $10.61 | $10.35 |
| Analyst Decision | Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $27.69 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 404.8K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $22.30 |
| Revenue Next Year | N/A | $69.17 |
| P/E Ratio | ★ N/A | $14.27 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.48 | $8.92 |
| 52 Week High | $31.80 | $17.65 |
Technical Indicators
Market Signals| Indicator | BHVN | SCZM |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 37.16 |
| Support Level | $8.40 | $8.92 |
| Resistance Level | $11.92 | $12.81 |
| Average True Range (ATR) | 0.64 | 0.80 |
| MACD | -0.10 | 0.16 |
| Stochastic Oscillator | 23.95 | 36.76 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About SCZM Santacruz Silver Mining Ltd. Common Shares
Santacruz Silver Mining Ltd is engaged in the operation, acquisition, exploration, and development of mineral properties in Latin America, with a primary focus on silver and zinc, including lead and copper. The company earns the majority of its revenue from Zinc and Silver. The company's reportable operating segments are the Bolivar mine and processing plant, the Porco mine and processing plant, the Caballo Blanco Group, San Lucas, Zimapan, and Corporate and Other activities. Key revenue is generated from Zimapan.